Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susumu Ohya

Showing results (71-80 of 122) with videos related to

Pageof 13
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|May 24, 2011
Intermediate-conductance Ca2+-activated K+ channel, KCa3.1, as a novel therapeutic target for benign prostatic hyperplasiaSusumu Ohya, Satomi Niwa, Yoshiyuki Kojima, et al.
Journal of Pharmacological Sciences|October 11, 2008
TRPV4-like non-selective cation currents in cultured aortic myocytesRyoichi Tanaka, Katsuhiko Muraki, Susumu Ohya, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|April 25, 2009
Molecular and functional characterization of Kv7 K+ channel in murine gastrointestinal smooth musclesThomas A Jepps, Iain A Greenwood, James D Moffatt, et al.
Bioorganic & Medicinal Chemistry Letters|November 1, 2003
Dehydroabietic acid derivatives as a novel scaffold for large-conductance calcium-activated K+ channel openersTomohiko Ohwada, Taro Nonomura, Keisuke Maki, et al.
Pflugers Archiv : European Journal of Physiology|November 21, 2016
Ryanodine receptor type 3 does not contribute to contractions in the mouse myometrium regardless of pregnancyKatsuhito Matsuki, Masashi Takemoto, Yoshiaki Suzuki, et al.
Molecular Pharmacology|January 10, 2019
Inhibition of Interleukin 10 Transcription through the SMAD2/3 Signaling Pathway by Ca<sup>2+</sup>-Activated K<sup>+</sup> Channel K<sub>Ca</sub>3.1 Activation in Human T-Cell Lymphoma HuT-78 CellsMiki Matsui, Junko Kajikuri, Hiroaki Kito, et al.
British Journal of Pharmacology|April 19, 2013
Role of the K(Ca)3.1 K+ channel in auricular lymph node CD4+ T-lymphocyte function of the delayed-type hypersensitivity modelSusumu Ohya, Erina Nakamura, Sayuri Horiba, et al.
Biochemical and Biophysical Research Communications|March 10, 2015
Regulation of store-operated Ca2+ entry activity by cell cycle dependent up-regulation of Orai2 in brain capillary endothelial cellsHiroaki Kito, Hisao Yamamura, Yoshiaki Suzuki, et al.
Biochemical and Biophysical Research Communications|November 14, 2016
Transcriptional repression of HER2 by ANO1 Cl<sup>-</sup> channel inhibition in human breast cancer cells with resistance to trastuzumabMayu Fujimoto, Takahiro Inoue, Hiroaki Kito, et al.
Journal of Pharmacological Sciences|November 21, 2016
Defective splicing of the background K<sup>+</sup> channel K<sub>2P</sub>5.1 by the pre-mRNA splicing inhibitor, pladienolide B in lectin-activated mouse splenic CD4<sup>+</sup> T cellsKazutaka Tagishi, Ayaka Shimizu, Kyoko Endo, et al.
Pageof 13

Showing results (71-80 of 122) with videos related to

Sort By:
Pageof 13
The Journal of Pharmacology and Experimental Therapeutics|May 24, 2011
Intermediate-conductance Ca2+-activated K+ channel, KCa3.1, as a novel therapeutic target for benign prostatic hyperplasiaSusumu Ohya, Satomi Niwa, Yoshiyuki Kojima, et al.
Journal of Pharmacological Sciences|October 11, 2008
TRPV4-like non-selective cation currents in cultured aortic myocytesRyoichi Tanaka, Katsuhiko Muraki, Susumu Ohya, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|April 25, 2009
Molecular and functional characterization of Kv7 K+ channel in murine gastrointestinal smooth musclesThomas A Jepps, Iain A Greenwood, James D Moffatt, et al.
Bioorganic & Medicinal Chemistry Letters|November 1, 2003
Dehydroabietic acid derivatives as a novel scaffold for large-conductance calcium-activated K+ channel openersTomohiko Ohwada, Taro Nonomura, Keisuke Maki, et al.
Pflugers Archiv : European Journal of Physiology|November 21, 2016
Ryanodine receptor type 3 does not contribute to contractions in the mouse myometrium regardless of pregnancyKatsuhito Matsuki, Masashi Takemoto, Yoshiaki Suzuki, et al.
Molecular Pharmacology|January 10, 2019
Inhibition of Interleukin 10 Transcription through the SMAD2/3 Signaling Pathway by Ca<sup>2+</sup>-Activated K<sup>+</sup> Channel K<sub>Ca</sub>3.1 Activation in Human T-Cell Lymphoma HuT-78 CellsMiki Matsui, Junko Kajikuri, Hiroaki Kito, et al.
British Journal of Pharmacology|April 19, 2013
Role of the K(Ca)3.1 K+ channel in auricular lymph node CD4+ T-lymphocyte function of the delayed-type hypersensitivity modelSusumu Ohya, Erina Nakamura, Sayuri Horiba, et al.
Biochemical and Biophysical Research Communications|March 10, 2015
Regulation of store-operated Ca2+ entry activity by cell cycle dependent up-regulation of Orai2 in brain capillary endothelial cellsHiroaki Kito, Hisao Yamamura, Yoshiaki Suzuki, et al.
Biochemical and Biophysical Research Communications|November 14, 2016
Transcriptional repression of HER2 by ANO1 Cl<sup>-</sup> channel inhibition in human breast cancer cells with resistance to trastuzumabMayu Fujimoto, Takahiro Inoue, Hiroaki Kito, et al.
Journal of Pharmacological Sciences|November 21, 2016
Defective splicing of the background K<sup>+</sup> channel K<sub>2P</sub>5.1 by the pre-mRNA splicing inhibitor, pladienolide B in lectin-activated mouse splenic CD4<sup>+</sup> T cellsKazutaka Tagishi, Ayaka Shimizu, Kyoko Endo, et al.
Pageof 13